Skip to content

Clinical research (COPD) using autologous fat tissue from the mesenchymal stem cells

Clinical research (COPD) using autologous fat tissue from the mesenchymal stem cells - Clinical research (COPD) using autologous fat tissue from the mesenchymal stem cells

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024133
Enrollment
6
Registered
2016-09-22
Start date
2016-07-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Medical corporation foundation Kouseikai Takeda Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For the subject of this study, Takeda Hospital respiratory organs physician and this study medical attendant perform confirmation, the medical examination of the anamnesis. Among patients meeting COPD diagnosis and guidelines diagnostic criteria of the guidelines fourth edition from the fourth edition editing Japan respiratory organs society COPD guidelines making Committeefor treatment, the purpose of this study is understood and intends for the patient of the chronic obstructive pulmonary disease to have a poor intractable disease in the effectiveness by the existing cure that obtained its consent in a document. Age, the sex do not matter. 1 The target disease patient who was admitted to the Takeda Hospital in an operation and treatment, an inspection purpose 2 The target disease patient who visits a hospital for treatment in the outpatient department of the Takeda Hospital 3 The patient who acquired an agreement of this study entry by the free will of the person in a document

Exclusion criteria

Exclusion criteria: The patient corresponding to the following standards excludes it from a patient targeted for the final examination. 1 The person that quantity of fat necessary for this study is not provided 2 The patient whom I am dialyzing 3 Pregnant patient 4 This study medical attendant is the patient who ethical, it is scientific, and made a decision from the viewpoint of safety if the participation in this study is inappropriate of the subject 5 The patient who needs Agent approval I confirm an anamnesis to advocate next and, from having experience or not that underwent a blood transfusion or transplant, do a competent thing judging. But I decide to reconfirm when I become able to confirm it about the anamnesis which I was not able to confirm at the time of a competent judgment later. 1 Infection with bacteria such as Treponema pallidum, a gonococcus, the tubercle bacillus 2 Sepsis and the doubt 3 Malignant tumor 4 Serious metabolism internal secretion disease 5 Serious blood disorder 6 Liver disease 7 Communicable spongy brain fever and the doubt 8 Family career to be concerned with a specific hereditary disease and the disease concerned 9 Pulmonary embolism

Design outcomes

Primary

MeasureTime frame
I evaluate the change of a symptom and the pulmonary function.Pulmonary function (the lung capacity, one second quantity), dyspnea (modified MRC), QOL, the hatred number of times, theweight, chest CT scanner, LAA %, nourishment evaluation

Countries

Japan

Contacts

Public ContactTadayuki Nakayama

Takeda Hospital group headquarters Director of medical management

nakayama@takedahp.or.jp0753611335

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026